Richard L. Gabriel
Chief Executive Officer at GLG Pharma LLC
Profile
Richard L.
Gabriel is the founder of GLG Pharma LLC, which was founded in 2009, where he holds the title of President & Chief Executive Officer.
He currently holds positions as a Director at Windgap Medical, Inc., MediVector, Inc., and Head-Life Science Practice at Semaphore, Inc. Mr. Gabriel's former positions include President & Chief Executive Officer at DNAPrint Genomics, Inc. from 2003 to 2009, President & Chief Executive Officer at Calix, Inc., Chief Executive Officer at DNAPrint Pharmaceuticals, Inc. from 2003 to 2009, Director at Trace Genetics, Inc. and Ellipsis Biotherapeutics Corp., and Member-Supervisory Board at Biofrontera AG from 2004 to 2010.
He also held the position of SVP-Research & Development at Predictive Oncology, Inc. from 2016 to 2022 and Chief Operating Officer at GLG Pharma SA. Mr. Gabriel received an MBA degree from Suffolk University and an undergraduate degree from Ohio Dominican University.
Richard L. Gabriel active positions
| Companies | Position | Start |
|---|---|---|
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Part of Roper Technologies, Inc., Semaphore, Inc. develops and distributes advanced financial and project management software. The private company is based in New York, NY. The company was founded by Omid C. Farokhzad. Semaphore was acquired by Deltek Systems, Inc. on August 10, 2000 for $10 million. | Corporate Officer/Principal | - |
| MediVector, Inc. | Corporate Officer/Principal | - |
Windgap Medical, Inc.
 Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Windgap Medical, Inc. engages in the development of epinephrine autoinjector for the treatment of anaphylaxis. The company was founded was founded by Christopher J. Stepanian and Brent Buchine and is headquartered in Somerville, MA. | Director/Board Member | - |
GLG Pharma LLC
 GLG Pharma LLC BiotechnologyHealth Technology GLG Pharma LLC operates as a biotechnology company. It develops personalized therapies for patients with cancer and other proliferative diseases. The company was founded by Hector J. Gomez, Richard H. Gabriel and Tony Frudakis in 2009 and is headquartered in Jupiter, FL. | Chief Executive Officer | 2008-12-31 |
Former positions of Richard L. Gabriel
| Companies | Position | End |
|---|---|---|
| PREDICTIVE ONCOLOGY INC. | Chief Tech/Sci/R&D Officer | 2022-09-29 |
| BIOFRONTERA AG | Director/Board Member | 2011-05-04 |
Ellipsis Biotherapeutics Corp.
 Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Director/Board Member | 2009-01-24 |
Trace Genetics, Inc.
 Trace Genetics, Inc. BiotechnologyHealth Technology Part of DNAPrint Genomics, Inc., Trace Genetics, Inc. provides products and services for the genealogy, forensics, and molecular diagnostics markets. The private company is based in Richmond, CA. Trace Genetics was acquired by DNAPrint Genomics, Inc. on June 21, 2005 for $0.38 million. | Director/Board Member | 2009-01-24 |
| DNAPRINT GENOMICS, INC. | Chief Executive Officer | 2008-12-31 |
Training of Richard L. Gabriel
| Suffolk University | Masters Business Admin |
| Ohio Dominican University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| DNAPRINT GENOMICS, INC. | Health Technology |
| BIOFRONTERA AG | Health Technology |
| CALIX, INC. | Electronic Technology |
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| GLG PHARMA S.A. | Health Technology |
| Private companies | 7 |
|---|---|
Windgap Medical, Inc.
Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Windgap Medical, Inc. engages in the development of epinephrine autoinjector for the treatment of anaphylaxis. The company was founded was founded by Christopher J. Stepanian and Brent Buchine and is headquartered in Somerville, MA. | Health Technology |
Semaphore, Inc.
Semaphore, Inc. Packaged SoftwareTechnology Services Part of Roper Technologies, Inc., Semaphore, Inc. develops and distributes advanced financial and project management software. The private company is based in New York, NY. The company was founded by Omid C. Farokhzad. Semaphore was acquired by Deltek Systems, Inc. on August 10, 2000 for $10 million. | Technology Services |
Trace Genetics, Inc.
Trace Genetics, Inc. BiotechnologyHealth Technology Part of DNAPrint Genomics, Inc., Trace Genetics, Inc. provides products and services for the genealogy, forensics, and molecular diagnostics markets. The private company is based in Richmond, CA. Trace Genetics was acquired by DNAPrint Genomics, Inc. on June 21, 2005 for $0.38 million. | Health Technology |
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
| MediVector, Inc. | |
Dnaprint Pharmaceuticals, Inc.
 Dnaprint Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Dnaprint Pharmaceuticals, Inc. develops theranostic genetic drug combinations. The private company is based in Sarasota, FL. | Commercial Services |
GLG Pharma LLC
GLG Pharma LLC BiotechnologyHealth Technology GLG Pharma LLC operates as a biotechnology company. It develops personalized therapies for patients with cancer and other proliferative diseases. The company was founded by Hector J. Gomez, Richard H. Gabriel and Tony Frudakis in 2009 and is headquartered in Jupiter, FL. | Health Technology |
- Stock Market
- Insiders
- Richard L. Gabriel
